Form 4 · Filed Jul 6, 2026, 09:51 PM UTC
ALLO/Allogene Therapeutics, Inc.
Roberts Zachary — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | A | other | 134,530 | — | — | 134,530 |
| Jul 1, 2026 | A | other | 476,190 | — | — | 476,190 |
Source: SEC EDGAR raw filing ↗ · Accession 0001851044-26-000005